Our Expertise
Orrive is built by Turning Point. We are a leading social enterprise, designing and delivering health and social care services in the fields of substance use, mental health, learning disability and sexual health.
Our vast experience of providing drug related advise is rooted in clinical, harm reduction and lived experience expertise. As such we strive to provide resources that you can trust and rely on.
Our Credentials
Turning Point is a registered charity (No. 234887) and a company limited by guarantee (No. 00793558).
We are registered with the Care Quality Commission (CQC No. 1-102642564) the independent regulator of health and adult social care in England. We embrace all the regulatory standards required by the CQC, as well as recognised field standards such as the Quality in Alcohol and Drug Standards (QuADS).
We are an Independent Provider of NHS services and a holder of an NHS improvements licence. Our certification of compliance with the licence conditions can be found here.
We work closely with the Public Health teams across local authorities who commission our services, the NHS, Integrated Care Boards (ICB), and the Office for Health Improvement and Disparities (OHID) among many other services to ensure we provide evidence based and person-centred care and support.
Turning Point’s registered office is America House, 2 America Square, London, EC3N 2LU.
Our Sources
Our vast experience of providing drug related advise is rooted in clinical, harm reduction and lived experience expertise. As such we strive to provide resources that you can trust and rely on.
Our healthcare information is informed by evidence-based clinical and social care guidance and industry best practice from the National Institute for Health and Care Excellence (NICE).
We utilise and recommend the following sources to obtain factual information about safer drug use and treatment provision:
Naloxone Medication
Naloxone is a life-saving medicine that can quickly reverse the effects and help someone breathe again. In the UK, anyone can carry and give naloxone - as long as it’s supplied to and used on people within the following age guidelines:
18+
- Injection: Prenoxad® 2 mg/ml (Ethypharm UK Ltd)
- Nasal Spray: Naloxone 1.26 mg (Accord-UK Ltd)
14+
- Nasal Spray: Nyxoid® 1.8 mg (Napp Pharmaceuticals Ltd)